Skip to content

Probiscend

Navigating Justice, Empowering Voices

  • Institutional Review Boards
  • Medicare Part D
  • Prescription Monitoring Programs
  • Food Drug and Cosmetic Act
  • Controlled Substances Act
  • Patient Safety Organization Standards
  • Telemedicine Regulation

Probiscend

Navigating Justice, Empowering Voices

  • Institutional Review Boards
  • Medicare Part D
  • Prescription Monitoring Programs
  • Food Drug and Cosmetic Act
  • Controlled Substances Act
  • Patient Safety Organization Standards
  • Telemedicine Regulation
Patent Term Extension
March 10, 2024 ProbiScend Team

An In-Depth Patent Term Extension Overview for Legal Professionals

Patent protection is vital for encouraging innovation, yet the initial 20-year patent term often falls short of safeguarding inventive efforts

Read More
Orphan Drug Act
March 10, 2024 ProbiScend Team

Understanding Orphan Drug Designation and Patent Rights in Legal Context

The designation of orphan drugs plays a pivotal role in incentivizing the development of treatments for rare diseases that often

Read More
Hatch Waxman Act
March 10, 2024 ProbiScend Team

Understanding the Process of Filing a Paragraph IV Certification in Patent Challenges

Filing a Paragraph IV certification is a pivotal step in the pharmaceutical patent landscape, especially under the provisions of the

Read More
Abbreviated New Drug Application
March 10, 2024 ProbiScend Team

The Significance of Good Manufacturing Practices in ANDA Approval Processes

Good Manufacturing Practices (GMP) are fundamental to ensuring the safety, efficacy, and quality of generic drugs submitted through Abbreviated New

Read More
Orphan Drug Act
March 10, 2024 ProbiScend Team

Exploring the Benefits of Orphan Drug Designation for Large Pharmaceutical Companies

The Orphan Drug Act has significantly transformed the landscape of pharmaceutical innovation by offering unique incentives for developing treatments for

Read More
Food Drug and Cosmetic Act
March 10, 2024 ProbiScend Team

Navigating the Legal Challenges in Food and Drug Law Compliance

The landscape of food and drug regulation is complex and continually evolving, driven by legal frameworks that aim to protect

Read More
New Drug Application Process
March 10, 2024 ProbiScend Team

Understanding the Role of Contract Research Organizations in the Legal and Clinical Sectors

The role of Contract Research Organizations (CROs) has become increasingly pivotal in the complex landscape of drug development and regulatory

Read More
Hatch Waxman Act
March 10, 2024 ProbiScend Team

Understanding the Fundamentals of Paragraph IV Certification Explained

Paragraph IV certification is a pivotal component in the landscape of patent litigation, especially within the framework established by the

Read More
Biologics License Application
March 10, 2024 ProbiScend Team

Ensuring Compliance through Quality Control Measures for Biologics

Ensuring the safety and efficacy of biologics requires rigorous quality control measures rooted in strict regulatory frameworks. These processes are

Read More
Orphan Drug Act
March 9, 2024 ProbiScend Team

Understanding the Orphan Drug Designation Benefits for Small Companies

The Orphan Drug Act has significantly transformed the landscape of rare disease treatment by incentivizing innovation. For small companies, obtaining

Read More
  • ← Previous
  • Next →
  • About
  • Contact Us
  • Privacy Policy
  • Disclaimer
  • Terms & Conditions